SCHEDULE: Vanguard Discloses 5.06% Stake in Phibro Animal Health

Vanguard Capital Management has reported beneficial ownership of 5.06% of Phibro Animal Health Corp.'s common stock as of March 31, 2026.

Summary

• Vanguard Capital Management, along with its affiliates, has disclosed a beneficial ownership stake of 5.06% in Phibro Animal Health Corp.
• The total number of shares beneficially owned is 1,043,822.
• Vanguard Capital Management holds sole voting power over 152,539 shares and sole dispositive power over 1,043,822 shares.
• The filing indicates that Vanguard funds and other managed accounts have the right to receive or direct the receipt of dividends and sale proceeds, but no single other person holds more than a 5% interest.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, indicating significant institutional interest from a major player like Vanguard, but without specific operational or financial performance data from Phibro Animal Health itself.

Positives

• Vanguard's investment signifies confidence in Phibro Animal Health's long-term prospects, potentially attracting further institutional interest.
• The disclosure confirms Phibro Animal Health's status as a publicly traded entity with significant institutional investor participation.

Negatives

• The filing does not contain any negative financial results or operational challenges for Phibro Animal Health.

Risks

• As a Schedule 13G filing, it primarily reports passive ownership stakes and does not inherently indicate any specific risks related to Phibro Animal Health's operations or financial health.

Future Outlook

This filing is a disclosure of ownership and does not contain forward-looking statements or guidance from Phibro Animal Health.

Industry Context

StockSavvy.ai notes that significant holdings by major asset managers like Vanguard in animal health companies often reflect a positive outlook on the sector's growth, driven by increasing global demand for animal protein and companion animal care.

Stakeholder Impact

• Shareholders may view Vanguard's increased stake as a positive signal of institutional confidence in the company.
• The filing does not directly impact employees, customers, suppliers, or creditors.

Key Dates

Keywords

Phibro Animal Health, Vanguard Capital Management, Schedule 13G, Beneficial Ownership, Institutional Investor, Common Stock, SEC Filing, Animal Health